MedPath
HSA Approval

KAPETRAL FILM-COATED TABLET 150MG

SIN15368P

KAPETRAL FILM-COATED TABLET 150MG

KAPETRAL FILM-COATED TABLET 150MG

November 29, 2017

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01BC06

capecitabine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD (BUILDING 5-ANTI-CANCER/HORMONES, BUILDING 10-ANTI-CANCER)

Active Ingredients

Capecitabine

150.000 mg

Capecitabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KAPETRAL FILM-COATED TABLET 150MG - HSA Approval | MedPath